Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-05 1:46:15 pm | Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting | GlobeNewsWire |
| 2024-02-29 1:5:0 pm | Prelude Therapeutics to Participate in Barclays Global Healthcare Conference | GlobeNewswire |
| 2024-02-17 4:34:4 am | Here's Why We're Watching Prelude Therapeutics' (NASDAQ:PRLD) Cash Burn Situation | Simply Wall St. |
| 2024-02-15 1:5:0 pm | Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024 | GlobeNewswire |
| 2024-01-14 6:24:39 am | Prelude Therapeutics Incorporated (NASDAQ:PRLD) is definitely on the radar of hedge funds investors who own 33% of the company | Simply Wall St. |
| 2024-01-02 4:11:0 am | Shell (SHEL) Resumes LNG Loading From Prelude Facility | Zacks |
| 2023-12-11 6:34:0 am | Prelude Therapeutics Announces $25 Million Private Placement | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information